• Contact Us
  • Career

Open menu

  • HOME
  • ABOUT US
    • About Us
    • Overview
    • Mission Statement, Vision & Core Values
    • History
    • Founders
    • Key Promoters and Directors
    • Corporate Governance
    • Our Recognition
  • PRODUCTS
    • PRODUCTS
    • Pharmaceuticals
    • Herbal & Nutraceuticals
    • Ayurvedic
    • Veterinary
  • FACILITIES
    • FACILITIES
    • General Unit
    • Solid Dosage Unit
    • Cephalosporins Unit
    • BFS, Liquid and Semi-Solid Unit
    • Veterinary Unit
    • Herbal and Ayurvedic Unit
    • Facility Gallery
  • BUSINESS OPERATIONS
    • BUSINESS OPERATIONS
    • Manufacturing
    • Quality Operation
    • Research and Development
    • QMS & Organization Development
    • Marketing, Sales & Distribution
    • Human Resources
    • Finance and Accounts
    • Corporate Affairs
    • Internal Audit
    • Information Technology
    • Global Operation
  • CSR
    • CSR
    • Commitment to the Employee
    • Commitment to the Society
    • Commitment to Environment
    • Triple Bottom Line (TBL) Reporting
    • Mass Extinction Crisis
  • INVESTORS CORNER
    • INVESTORS CORNER
    • Key Promoters and Directors
    • Corporate Brief
    • Directors’ Report
    • Financial Reports
    • Price Sensitive Information
    • Shareholding Position
    • C G Compliance Status
    • Annual General Meeting
    • Use of IPO Proceeds
    • Share Information
    • Investor Relations’ Contact
image01
  • Gliclid

    Composition:

    Gliclid 80: Each tablet contains Gliclazide BP 80 mg.

    Gliclid MR: Each modified release tablet contains Gliclazide BP 30 mg.

    Gliclid 60 MR: Each modified release tablet contains Gliclazide BP 60 mg.

     

    Indications

    Gliclazide is indicated-

    - for the control of blood glucose in people with type 2 diabetes. It is used when diet, exercise, and weight reduction have not been found to control blood glucose well enough without medication.

     

    Dosage and Administration

    The total daily dose may vary from 40-320mg. The dose should be adjusted according to the individual's response, commencing with 40-80mg daily and increasing until adequate control is achieved. A single dose should not exceed 160mg. When higher doses are required, Gliclazide should be taken twice daily and according to the main meals of the day.

    The daily dose of Gliclazide MR Tablet may vary from 30 to 120 mg once daily. The recommended starting dose of Gliclazide MR is 30 mg daily. Dose adjustment should be carried out in steps of 30 mg, according to the blood glucose response.  Each step should last for at least two weeks.

    OR, AS DIRECTED BY PHYSICIAN.

    Prescribing Details

Related Products

  • DACTUS

    DACTUS

    Glimepiride
    DAOMIN

    DAOMIN

    Metformin HCl
    GLICLID

    GLICLID

    Gliclazide BP
    JANMET

    JANMET

    Sitagliptin+Metformin
    JANVIA

    JANVIA

    Sitagliptin
    LINO

    LINO

    Linagliptin
    Lino M

    Lino M

    Linagliptin INN & Metformin Hc
    VILDAPIN

    VILDAPIN

    Vildagliptin
    VILDAPIN PLUS

    VILDAPIN PLUS

    Vildagliptin + Metformin
.
  • About Us
    • Overview
    • Mission Statement, Vision & Core Values
    • History
    • Founders
    • Key Promoters and Directors
    • Corporate Governance
    • Our Recognition
  • PRODUCTS
    • Pharmaceuticals
    • Herbal & Neutraceutical
    • Ayurvedic
    • Veterinary
  • Contact Us
    • Corporate
    • Sales Center
    • Plant
    • Drug Safety
  • DOCTORS CORNER
    • Feedback
    • Query
    • Events
    • Publications
      • Medical Digest
      • Shashtho Kotha
      • Case Studies
    • Selective Therapeutic Information
Copyright © 2019 ACME | Developed by ACME-IT Division.